At the same time, due to the difficult-to-target biological characteristics of MYC, targeting the downstream targets of MYC to form a synthetic lethal strategy may be more effective in this subtype of cancer patients (Nijman and Friend, 2013; Solvie et al., 2022; Sun et al., 2022). Here, MYC is linked to cancer.